• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Financial Toxicity Interventions in Hematologic Malignancies Are Timely and Necessary.血液系统恶性肿瘤中的经济毒性干预措施既及时又必要。
JCO Oncol Pract. 2022 Sep;18(9):607-609. doi: 10.1200/OP.22.00357. Epub 2022 Jul 8.
2
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions.血液系统恶性肿瘤患者的财务毒性：综述与干预需求。
Curr Hematol Malig Rep. 2023 Oct;18(5):158-166. doi: 10.1007/s11899-023-00707-6. Epub 2023 Jul 25.
3
Financial toxicity, coping strategies, and quality of life among Chinese patients with hematologic malignancies: a cross-sectional study.中国血液恶性肿瘤患者的财务毒性、应对策略和生活质量：一项横断面研究。
Support Care Cancer. 2024 Jul 2;32(7):475. doi: 10.1007/s00520-024-08693-y.
4
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System.在全民医保体系下治疗血液系统恶性肿瘤患者的财务毒性和健康相关生活质量特征。
JCO Oncol Pract. 2024 Mar;20(3):438-447. doi: 10.1200/OP.23.00434. Epub 2024 Jan 11.
5
Financial toxicity in hematological malignancies: a systematic review.血液恶性肿瘤中的财务毒性：系统评价。
Blood Cancer J. 2022 Apr 22;12(4):74. doi: 10.1038/s41408-022-00671-z.
6
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy.金融毒性干预改善血液系统恶性肿瘤患者的预后。
JCO Oncol Pract. 2022 Sep;18(9):e1494-e1504. doi: 10.1200/OP.22.00056. Epub 2022 Jun 16.
7
Financial toxicity in patients with leukemia undergoing hematopoietic stem cell transplantation: A systematic review.白血病患者接受造血干细胞移植后的财务毒性：系统评价。
Best Pract Res Clin Haematol. 2023 Jun;36(2):101469. doi: 10.1016/j.beha.2023.101469. Epub 2023 Apr 19.
8
Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.血液系统恶性肿瘤患者是否承受经济负担？一项针对通过公共资助医疗系统寻求治疗的患者的横断面研究。
Leuk Res. 2022 Jan;112:106748. doi: 10.1016/j.leukres.2021.106748. Epub 2021 Nov 10.
9
Links: Addressing Financial Toxicity Among Patients With Hematologic Cancer and Their Caregivers.链接：解决血液系统恶性肿瘤患者及其照护者的经济毒性问题。
JCO Oncol Pract. 2023 May;19(5):e696-e705. doi: 10.1200/OP.22.00665. Epub 2023 Mar 8.
10
Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation.血液系统恶性肿瘤中的铁过载与异基因造血干细胞移植的结局
Haematologica. 2010 Mar;95(3):364-6. doi: 10.3324/haematol.2009.017244.

引用本文的文献

1
Addressing financial hardship in malignant hematology and hematopoietic cell transplant: a team approach.解决恶性血液病和造血细胞移植中的经济困难：团队方法。
Blood Adv. 2024 Oct 8;8(19):5146-5155. doi: 10.1182/bloodadvances.2024012998.
2
Interventions to mitigate cancer-related medical financial hardship: A systematic review and meta-analysis.减轻癌症相关医疗财务困难的干预措施：系统评价和荟萃分析。
Cancer. 2024 Sep 15;130(18):3198-3209. doi: 10.1002/cncr.35367. Epub 2024 May 17.
3
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions.血液系统恶性肿瘤患者的财务毒性：综述与干预需求。
Curr Hematol Malig Rep. 2023 Oct;18(5):158-166. doi: 10.1007/s11899-023-00707-6. Epub 2023 Jul 25.
4
Financial Toxicity Order Set: Implementing a Simple Intervention to Better Connect Patients With Resources.财务毒性医嘱单：实施一项简单干预措施，更好地为患者提供资源。
JCO Oncol Pract. 2023 Aug;19(8):662-668. doi: 10.1200/OP.22.00669. Epub 2023 Jun 15.

本文引用的文献

1
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy.金融毒性干预改善血液系统恶性肿瘤患者的预后。
JCO Oncol Pract. 2022 Sep;18(9):e1494-e1504. doi: 10.1200/OP.22.00056. Epub 2022 Jun 16.
2
Financial toxicity in hematological malignancies: a systematic review.血液恶性肿瘤中的财务毒性：系统评价。
Blood Cancer J. 2022 Apr 22;12(4):74. doi: 10.1038/s41408-022-00671-z.
3
Divergent Patterns in Care Utilization and Financial Distress between Patients with Blood Cancers and Solid Tumors: A National Health Interview Survey Study, 2014-2020.血癌与实体瘤患者在医疗服务利用和财务困境方面的不同模式：2014 - 2020年全国健康访谈调查研究
Cancers (Basel). 2022 Mar 22;14(7):1605. doi: 10.3390/cancers14071605.
4
Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.血液系统恶性肿瘤患者是否承受经济负担？一项针对通过公共资助医疗系统寻求治疗的患者的横断面研究。
Leuk Res. 2022 Feb;113:106786. doi: 10.1016/j.leukres.2022.106786. Epub 2022 Jan 19.
5
Development of a Financial Toxicity Screening Tool for Radiation Oncology: A Secondary Analysis of a Pilot Prospective Patient-Reported Outcomes Study.放射肿瘤学财务毒性筛查工具的开发：一项前瞻性患者报告结局试点研究的二次分析
Adv Radiat Oncol. 2021 Sep 11;6(6):100782. doi: 10.1016/j.adro.2021.100782. eCollection 2021 Nov-Dec.
6
Evidence of the Feasibility and Preliminary Efficacy of Oncology Financial Navigation: A Scoping Review.肿瘤学财务导航可行性和初步疗效的证据：范围综述。
Cancer Epidemiol Biomarkers Prev. 2021 Oct;30(10):1778-1784. doi: 10.1158/1055-9965.EPI-20-1853. Epub 2021 Aug 2.
7
Affordable Care Act and Cancer Survivors' Financial Barriers to Care: Analysis of the National Health Interview Survey, 2009-2018.平价医疗法案与癌症幸存者的医疗经济障碍：基于 2009-2018 年国家健康访谈调查的分析。
JCO Oncol Pract. 2021 Oct;17(10):e1603-e1613. doi: 10.1200/OP.21.00095. Epub 2021 Jul 13.
8
Identifying a cut-off score for the COST measure to indicate high financial toxicity and low quality of life among cancer patients.确定 COST 量表的截断值，以表明癌症患者的财务毒性高和生活质量低。
Support Care Cancer. 2021 Oct;29(10):6109-6117. doi: 10.1007/s00520-020-05962-4. Epub 2021 Apr 2.
9
Cancer Statistics, 2021.癌症统计数据，2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
10
Assessment of Financial Toxicity Among Older Adults With Advanced Cancer.评估晚期癌症老年患者的财务毒性。
JAMA Netw Open. 2020 Dec 1;3(12):e2025810. doi: 10.1001/jamanetworkopen.2020.25810.

Financial Toxicity Interventions in Hematologic Malignancies Are Timely and Necessary.

作者信息

Su Christopher T

机构信息

Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.

Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI.

出版信息

JCO Oncol Pract. 2022 Sep;18(9):607-609. doi: 10.1200/OP.22.00357. Epub 2022 Jul 8.

DOI:10.1200/OP.22.00357
PMID:35802841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9509202/
Abstract
摘要